市场调查报告书
商品编码
1603798
生物医学感测器的全球市场预测(-2030):按产品类型、感测器类型、连接性、应用、最终用户和区域进行分析Biomedical Sensor Market Forecasts to 2030 - Global Analysis By Product Type, Sensor Type, Connectivity, Application, End User and By Geography |
根据Stratistics MRC预测,2024年全球生物医学感测器市场规模预计将达到107亿美元,2030年将达到178亿美元,预测期内复合年增长率为8.8%。
生物医学感测器是透过检测和测量体温、血压、心率和血糖浓度等生物讯号和参数来监测人类健康的设备。这些感测器透过将生理资料转换为电讯号进行分析,有助于疾病诊断、治疗监测和患者护理。穿戴式科技、诊断工具和医疗植入都使用生物医学感测器来提供即时健康监测,并实现量身定制的医疗干预措施,以获得更好的结果。
根据世界卫生组织 (WHO) 统计,2021 年,心血管疾病和糖尿病等慢性疾病影响了全球约 5.37 亿成年人。
对病患监测的需求增加
慢性病的流行和人口老化增加了对病患监测系统的需求。生物医学感测器能够持续即时监测生命征象和其他健康参数,从而能够及早发现并及时干预健康问题。这一趋势正在推动生物医学感测器在医疗保健和居家照护环境中的采用,从而推动市场成长。
安全问题
生物医学感测器与连接设备和网路的整合引起了对资料安全和患者隐私的担忧。未授权存取敏感医疗资讯可能会导致洩漏机密和资料滥用。此类安全风险可能会阻碍生物医学感测器的广泛采用,特别是在医疗机构和注重隐私的个人中,从而抑制市场成长。
医疗保健支出增加
全球医疗保健支出的成长对于生物医学感测器市场来说是一个巨大的机会。随着政府和私营部门增加对医疗保健基础设施和先进医疗技术的投资,对包含生物医学感测器的先进监测和诊断工具的需求预计将会增加。这种趋势在医疗保健系统正在快速现代化的新兴国家尤其明显。
医疗保健监管的变化
生物医学感测器市场面临着不断发展的医疗法规和标准的潜在威胁。对包括感测器在内的医疗设备的严格监管要求可能会导致产品开发週期更长和成本更高。此外,报销政策的变化可能会影响医疗保健环境中基于感测器的技术的采用。这些监管不确定性给市场相关人员带来了挑战,并可能影响成长轨迹。
COVID-19 大流行对生物医学感测器市场产生了重大影响。最初,供应链中断和製造业放缓造成了暂时的挫折。然而,疫情加速了远端患者监护解决方案和远端医疗服务的采用,推动了对生物医学感测器的需求。在医院和家庭护理环境中持续监测患者生命征象的需求进一步推动了市场成长。长期影响包括个人健康监测意识的提高以及向预防性医疗保健的转变,从而使生物医学感测器市场受益。
非侵入式感测器领域预计将在预测期内成为最大的领域
由于其卓越的患者舒适度和易用性,预计非侵入式感测器领域将在预测期内获得最大的市场占有率。这些感测器可以在不破坏皮肤或进入体腔的情况下监测各种生理参数,使其成为连续监测和家庭医疗保健应用的理想选择。与侵入式感测器相比,非侵入式感测器还可以降低感染和併发症的风险。对微创医疗程序的日益偏好以及穿戴式健康设备的日益普及正在推动这一领域的主导地位。
生物分析感测器领域预计在预测期内复合年增长率最高
预计生物分析感测器领域将在预测期内显着增长。这些感测器旨在检测和测量体内特定的生物或化学物质,具有高灵敏度和选择性。对个人化医疗、照护现场诊断和各种疾病生物标记持续监测的日益关注正在推动对生物分析感测器的需求。此外,奈米技术和材料科学的进步正在增强这些感测器的功能,从而可以对复杂的生物样品进行快速、准确且经济高效的分析。
预计在预测期内,北美将占据生物医学感测器市场的最大份额。这一优势归因于多种因素,包括先进的医疗基础设施、高昂的医疗成本以及早期采用创新医疗技术。该地区拥有许多领先的医疗设备製造商和研究机构,为感测器技术的持续创新做出了贡献。此外,慢性病的高盛行率和人口老化正在推动对采用生物医学感测器的先进病患监测解决方案的需求。
亚太地区预计将在生物医学感测器市场实现最高的复合年增长率。中国和印度等国家的快速经济成长、医疗保健支出的增加以及医疗保健基础设施的改善正在推动市场扩张。该地区庞大且不断增长的人口以及预防保健意识的不断增强正在为生物医学感测器创造一个巨大的市场。此外,旨在实现医疗保健系统现代化和增加数位医疗技术采用的政府措施也促进了该地区市场的高成长率。
According to Stratistics MRC, the Global Biomedical Sensor Market is accounted for $10.7 billion in 2024 and is expected to reach $17.8 billion by 2030, growing at a CAGR of 8.8% during the forecast period. A biomedical sensor is a device used to monitor a person's health by detecting and measuring biological signals or parameters, such as temperature, blood pressure, heart rate, or glucose levels. These sensors help with disease diagnosis, treatment monitoring, and patient care by converting physiological data into electrical signals for analysis. Wearable technology, diagnostic tools, and medical implants all use biomedical sensors to provide real-time health monitoring and enable tailored medical interventions for better results.
According to the World Health Organization (WHO), chronic diseases such as cardiovascular diseases and diabetes affected approximately 537 million adults globally in 2021.
Increased demand for patient monitoring
The growing prevalence of chronic diseases and an aging population have led to increased demand for patient monitoring systems. Biomedical sensors enable continuous, real-time monitoring of vital signs and other health parameters, allowing for early detection of health issues and timely interventions. This trend is driving the adoption of biomedical sensors in healthcare settings and home care environments, fueling market growth.
Security concerns
The integration of biomedical sensors with connected devices and networks raises concerns about data security and patient privacy. Unauthorized access to sensitive health information could lead to breaches of confidentiality and potential misuse of data. These security risks may hinder the widespread adoption of biomedical sensors, particularly in healthcare institutions and among privacy-conscious individuals, thus restraining market growth.
Growing healthcare expenditure
Increasing healthcare expenditure worldwide presents a significant opportunity for the biomedical sensors market. As governments and private sectors invest more in healthcare infrastructure and advanced medical technologies, the demand for sophisticated monitoring and diagnostic tools incorporating biomedical sensors is expected to rise. This trend is particularly pronounced in emerging economies, where healthcare systems are rapidly modernizing.
Changes in healthcare regulations
The biomedical sensors market faces potential threats from evolving healthcare regulations and standards. Stringent regulatory requirements for medical devices, including sensors, can lead to longer product development cycles and increased costs. Additionally, changes in reimbursement policies may affect the adoption of sensor-based technologies in healthcare settings. These regulatory uncertainties could pose challenges to market players and impact growth trajectories.
The COVID-19 pandemic significantly impacted the biomedical sensors market. Initially, supply chain disruptions and manufacturing slowdowns caused temporary setbacks. However, the pandemic also accelerated the adoption of remote patient monitoring solutions and telehealth services, driving demand for biomedical sensors. The need for continuous monitoring of COVID-19 patients' vital signs in hospitals and home care settings further boosted market growth. Long-term effects include increased awareness of personal health monitoring and a shift towards preventive healthcare, benefiting the biomedical sensors market.
The non-invasive sensors segment is expected to be the largest during the forecast period
The non-invasive sensors segment is predicted to secure the largest market share throughout the forecast period due to their advantages in patient comfort and ease of use. These sensors can monitor various physiological parameters without breaking the skin or entering body cavities, making them ideal for continuous monitoring and home healthcare applications. Non-invasive sensors also offer reduced risk of infection and complications compared to invasive alternatives. The growing preference for minimally invasive medical procedures and the increasing adoption of wearable health devices contribute to this segment's dominance.
The bioanalytic sensors segment is expected to have the highest CAGR during the forecast period
The bioanalytic sensors segment is projected to witness substantial growth during the projection period. These sensors are designed to detect and measure specific biological or chemical substances in the body, offering high sensitivity and selectivity. The increasing focus on personalized medicine, point-of-care diagnostics, and continuous monitoring of biomarkers for various diseases drives the demand for bioanalytic sensors. Furthermore, advancements in nanotechnology and materials science are enhancing the capabilities of these sensors, enabling rapid, accurate, and cost-effective analysis of complex biological samples.
North America is expected to hold the largest share in the biomedical sensors market during the forecast period. This dominance is attributed to several factors, including advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative medical technologies. The region's strong presence of leading medical device manufacturers and research institutions contributes to continuous innovation in sensor technologies. Additionally, the high prevalence of chronic diseases and an aging population drive the demand for advanced patient monitoring solutions incorporating biomedical sensors.
The Asia Pacific region is projected to achieve the highest CAGR in the biomedical sensors market. Rapid economic growth, increasing healthcare expenditure, and improving healthcare infrastructure in countries like China and India are driving market expansion. The region's large and growing population, coupled with rising awareness of preventive healthcare, creates a substantial market for biomedical sensors. Additionally, government initiatives to modernize healthcare systems and the increasing adoption of digital health technologies further contribute to the region's high growth rate in the market.
Key players in the market
Some of the key players in Biomedical Sensor Market include GE Healthcare, Analog Devices, Inc., STMicroelectronics N.V., Medtronic PLC, NXP Semiconductor N.V., Honeywell International Inc., Texas Instruments, Nonin Medical Inc., First Sensor AG, Smiths Medical, Measurement Specialties, Inc., LumaSense Technologies, Zephyr Technology Corp., Innovative Sensor Technology USA, and Amphenol Corporation.
In October 2024, Medtronic has introduced the Nellcor(TM) OxySoft(TM) SpO2 sensor, which uses silicone adhesive to protect fragile skin and improve repositionability. This sensor is designed for critical care patients and provides continuous oxygen saturation monitoring.
In April 2024, Nonin Medical has partnered with Medixine to integrate pulse oximetry devices into a digital remote patient monitoring platform. This collaboration aims to streamline overnight oxygen therapy pre-screening using Nonin's wearable devices.
In January 2024, Amphenol has expanded its sensor portfolio through acquisitions of companies like LID (pressure sensors) and PCTEL (wireless technology). These acquisitions will enhance Amphenol's offerings in medical sensor technologies.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.